For women navigating fertility challenges—particularly those pursuing assisted reproduction at older ages—the molecular biology of the uterine lining has long been an underexplored frontier. While much reproductive aging research has centered on eggs and ovaries, emerging evidence now points to the endometrium itself as a critical variable, shaped by senescence pathways that may determine whether implantation succeeds or fails.
This review, drawing on a PubMed literature search through October 2025, synthesizes evidence on p16 (cyclin-dependent kinase inhibitor 2A, encoded by CDKN2A) as a key regulator of endometrial cell fate. p16 is a well-characterized tumor suppressor and senescence effector that halts the cell cycle by inhibiting CDK4/6-mediated phosphorylation of retinoblastoma protein. The authors propose a two-phase conceptual framework: in a functional phase, appropriately expressed and spatially distributed p16 may support decidualization—the transformation of endometrial stromal cells essential for embryo acceptance—and pregnancy maintenance. In a persistent senescent phase, however, chronically elevated p16 expression may drive senescence-associated secretory phenotype (SASP) signaling, recruiting monocytes, macrophages, and other immune effectors in ways that promote chronic inflammation and endometrial dysfunction, potentially undermining ART outcomes.
The framing here is intellectually significant because it repositions endometrial senescence not as uniformly harmful but as context-dependent—a distinction with real clinical implications. The SASP-immune axis is particularly compelling: p16-positive senescent cells appear capable of remodeling the local immune microenvironment, which is already known to be exquisitely regulated during implantation. That said, this is a narrative review, not a meta-analysis or clinical trial, so causal claims remain premature. The human endometrial data are sparse, methodologically heterogeneous, and largely correlational. Whether p16 is a tractable therapeutic target in reproductive medicine—through senolytics, senomorphics, or cycle-timed interventions—remains speculative. This is an incremental but directionally important synthesis that should motivate prospective mechanistic studies.
